Pregabalin
Chemotherapy Induced Neuropathic Pain
University of RochesterSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
29 Active assets in the Chemotherapy Induced Neuropathic Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Omeprazole Aya Mohamed Sadek Elsaid | Phase 3 | BB |
LIDOCAINE Hospital Ambroise Paré Paris | Phase 2 | BB |
Vitamin B6 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2/3 | B |
Mecobalamin Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2/3 | B |
Sodium Selenite Pentahydrate Seoul National University Hospital | Phase 3 | B |
View all 46 →
Same molecule, other indications
Pregabalin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →